3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
5
Phase NA
2
Phase 2/3
2
Phase EARLY_PHASE1
1
Phase 3
1
Phase 1/2
1
Phase 1
1
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Tumor-Agnostic
1
Conditions
Breast Neoplasms
2
Parasomnias
1
Pain
1
Depression
1
Anxiety Disorders
1
Interventions
Capecitabine
17
Paclitaxel
16
Docetaxel
13
Carboplatin
12
Cyclophosphamide
11
Gemcitabine
9
Epirubicin
9
Trastuzumab
8
Letrozole
8
Doxorubicin
7
pertuzumab
5
Cisplatin
5
Vinorelbine
4
130-nm albumin-bound paclitaxel
4
exemestane
3
Zoledronic Acid
3
Tamoxifen
3
Neoadjuvant Therapy
3
Lapatinib
3
Injections
3
Drug Therapy
3
Ado-Trastuzumab Emtansine
3
AC protocol
3
pyrotinib
2
palbociclib
2
camrelizumab
2
apatinib
2
Thiotepa
2
Taxes
2
Standard of Care
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
Melatonin
×
Breast
×
Clear all
NCT01557478
2015-01-08
MIQOL-B
Khon Kaen University
Phase 2/3
Unknown
166 enrolled
NCT01355523
2014-05-06
MELODY
Herlev Hospital
Phase 2/3
Terminated
54 enrolled
27 charts